Cancer Prevention & Control
Cancer Prevention and Control (CPC) researchers are engaged in innovative and collaborative research with the potential to decrease cancer morbidity and mortality. CPC researchers are also involved in prevention and early detection of cancer through cancer risk reduction and screening as well as preventing and reducing debilitating symptoms caused by cancer treatment while tailoring interventions to individuals. The program’s themes focus on two crucial challenges across the cancer continuum: 1.) preventing the occurrence of cancer and detecting it early whenever possible by increasing the effectiveness and adherence to cancer screening; and 2.) identifying mechanisms of treatment-related toxicities (neuropathy and cognitive dysfunction) and developing interventions to improve the quality of cancer care, including supportive care, and reducing symptom burden from cancer therapies.
Scientific goals: The scientific goals of the program are advanced by focused work in three themes:
Theme 1: Prevention (HPV and lung cancer)
Aim 1: Understand the transmission of HPV (e.g., modes of HPV transmission and vaccines) and reduce the incidence of HPV-related cancers through improving rates of vaccination and safe sexual practices.
Aim 2: Decrease the prevalence of tobacco use through smoking cessation, prevention of tobacco uptake, and reducing relapse through translation of evidence based tobacco reduction interventions to the community.
Theme 2: Early detection
Aim 1: Develop and implement risk-based and cost effective methods of delivering colorectal cancer screening.
Aim 2: Test translation and cost-effectiveness of tailored interventions to increase cervical, breast, and colorectal cancer screening.
Theme 3: Survivorship
Aim 1: Evaluate mechanisms, treatment, and prevention of chemotherapy-induced neurotoxicities, particularly peripheral neuropathy and cognitive dysfunction.
Aim 2: Detect and test interventions to alleviate symptom burden in cancer patients and their families.